Yeast as a Heterologous Model System to Uncover Type III Effector Function

28Citations
Citations of this article
104Readers
Mendeley users who have this article in their library.

Abstract

Type III effectors (T3E) are key virulence proteins that are injected by bacterial pathogens inside the cells of their host to subvert cellular processes and contribute to disease. The budding yeast Saccharomyces cerevisiae represents an important heterologous system for the functional characterisation of T3E proteins in a eukaryotic environment. Importantly, yeast contains eukaryotic processes with low redundancy and are devoid of immunity mechanisms that counteract T3Es and mask their function. Expression in yeast of effectors from both plant and animal pathogens that perturb conserved cellular processes often resulted in robust phenotypes that were exploited to elucidate effector functions, biochemical properties, and host targets. The genetic tractability of yeast and its amenability for high-throughput functional studies contributed to the success of this system that, in recent years, has been used to study over 100 effectors. Here, we provide a critical view on this body of work and describe advantages and limitations inherent to the use of yeast in T3E research. “Favourite” targets of T3Es in yeast are cytoskeleton components and small GTPases of the Rho family. We describe how mitogen-activated protein kinase (MAPK) signalling, vesicle trafficking, membrane structures, and programmed cell death are also often altered by T3Es in yeast and how this reflects their function in the natural host. We describe how effector structure–function studies and analysis of candidate targeted processes or pathways can be carried out in yeast. We critically analyse technologies that have been used in yeast to assign biochemical functions to T3Es, including transcriptomics and proteomics, as well as suppressor, gain-of-function, or synthetic lethality screens. We also describe how yeast can be used to select for molecules that block T3E function in search of new antibacterial drugs with medical applications. Finally, we provide our opinion on the limitations of S. cerevisiae as a model system and its most promising future applications.

References Powered by Scopus

A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae

4003Citations
N/AReaders
Get full text

Genomic expression programs in the response of yeast cells to environmental changes

3943Citations
N/AReaders
Get full text

Global analysis of protein localization in budding yeast

3486Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The effector AWR5 from the plant pathogen Ralstonia solanacearum is an inhibitor of the TOR signalling pathway

52Citations
N/AReaders
Get full text

Modification of bacterial effector proteins inside Eukaryotic host cells

41Citations
N/AReaders
Get full text

The toolbox for uncovering the functions of legionella Dot/Icm Type IVb secretion system effectors: Current state and future directions

33Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Popa, C., Coll, N. S., Valls, M., & Sessa, G. (2016, February 1). Yeast as a Heterologous Model System to Uncover Type III Effector Function. PLoS Pathogens. Public Library of Science. https://doi.org/10.1371/journal.ppat.1005360

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 39

58%

Researcher 12

18%

Professor / Associate Prof. 10

15%

Lecturer / Post doc 6

9%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 36

48%

Biochemistry, Genetics and Molecular Bi... 28

37%

Immunology and Microbiology 9

12%

Medicine and Dentistry 2

3%

Article Metrics

Tooltip
Mentions
News Mentions: 1
Social Media
Shares, Likes & Comments: 6

Save time finding and organizing research with Mendeley

Sign up for free